Doxorubicin and tamoxifen loaded graphene oxide nanoparticle functionalized with chitosan and folic acid for anticancer drug delivery

Neşe Keklikçioğlu Çakmak; Atakan Eroğlu

doi:10.1007/s00289-022-04549-9

ScienceGate Book Chapters

JOURNAL ARTICLE

Doxorubicin and tamoxifen loaded graphene oxide nanoparticle functionalized with chitosan and folic acid for anticancer drug delivery

Neşe Keklikçioğlu Çakmak Atakan Eroğlu

Year: 2022 Journal: Polymer Bulletin Vol: 80 (2)Pages: 2171-2185 Publisher: Springer Science+Business Media

DOI: 10.1007/s00289-022-04549-9

Get Full-Text PDF Get Analytical Report

Keywords:

Zeta potential Nanocarriers Graphene Chitosan Drug delivery Conjugate Chemistry Nuclear chemistry Doxorubicin Nanoparticle Materials science Combinatorial chemistry Nanotechnology Organic chemistry Medicine Chemotherapy

Metrics

Cited By

1.22

FWCI (Field Weighted Citation Impact)

Refs

0.70

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Graphene and Nanomaterials Applications

Physical Sciences → Engineering → Biomedical Engineering

Nanoparticle-Based Drug Delivery

Physical Sciences → Materials Science → Biomaterials

Graphene research and applications

Physical Sciences → Materials Science → Materials Chemistry

Doxorubicin and tamoxifen loaded graphene oxide nanoparticle functionalized with chitosan and folic acid for anticancer drug delivery

Metrics

Citation History

Topics

Related Documents

Camptothecin loaded graphene oxide nanoparticle functionalized with polyethylene glycol and folic acid for anticancer drug delivery

Ulvan loaded graphene oxide nanoparticle fabricated with chitosan and d-mannose for targeted anticancer drug delivery

Design of functionalized folic acid–chitosan nanoparticles for delivery of tetracycline, doxorubicin, and tamoxifen

Folic acid-conjugated iron oxide porous nanorods loaded with doxorubicin for targeted drug delivery

Lactobionic acid and carboxymethyl chitosan functionalized graphene oxide nanocomposites as targeted anticancer drug delivery systems